LACHENAIE, QC,
Dec. 20, 2013 /CNW Telbec/ - Capital
Pro-Égaux Inc. (the "Company") (NEX: CPE.H) announces that its
wholly owned subsidiary, Technique d'usinage Sinlab Inc.
("Sinlab"), has filed an action for damages it believes are the
result of professional malpractice of certain former legal counsels
of Sinlab in connection with matters pertaining to the recently
announced settlements involving Delcam USA, Inc. and Delcam Holdings, Inc., Cagenix,
Inc., Dentsply International Inc. and the Nobel Entities, comprised
of Nobel Biocare AB; Nobel Biocare Italiana S.r.l.; Nobel Biocare
Holding AG; Nobel Biocare Deutschland GmbH; Nobel Biocare Canada,
Inc.; Biocad Médical Inc.; Nobel Biocare USA, LLC; and Nobel Biocare Procera, LLC.
Caution regarding forward-looking
statements
This news release contains certain
forward-looking statements regarding the Company's expectation of
future events, including potential claims and legal proceedings.
Such expectations are based on certain assumptions based on
currently available information. If these assumptions prove
incorrect, actual results may differ materially from those
contemplated by the forward-looking statements contained in this
press release. Factors that could lead actual results to differ
include, amongst others, factors that may impact claims and legal
proceedings, such as interpretation of factual matters, time and
money involved in undertaking legal proceedings, uncertainty as to
the final result and other risks. The Company disclaims any
intention or obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, other than as required by securities
laws.
About Pro-Égaux Inc.
Pro-Égaux through its wholly owned subsidiary,
Technique d'usinage Sinlab Inc., is a company based in Lachenaie, Quebec, specializing mainly in the
conception and design of titanium products to be used in the dental
prosthesis restoration industry.
Neither NEX, the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of NEX and the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
SOURCE Capital Pro-Égaux Inc.